Israelândia, Goias, Brazil Medison Pharma is the famous Corporate Investor, which was founded in 1996. The main department of described Corporate Investor is located in the Israelu00e2ndia. The fund was located in South America if to be more exact in Brazil.
The standard case for the fund is to invest in rounds with 5 partakers. The meaningful sponsors for the fund in investment in the same round are Pontifax, Partners Innovation Fund, Global health sciences venture fund.
The usual things for fund are deals in the range of 10 - 50 millions dollars. The top activity for fund was in 2019. The fund is generally included in less than 2 deals every year.
Besides, a startup needs to be aged 4-5 years to get the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight Keros Therapeutics. For fund there is no match between the country of its foundation and the country of its the most frequent investments - United States. Among the most popular fund investment industries, there are Pharmaceutical, Biotechnology.
Related Funds
| Fund Name | Location |
| Bank of Beijing | Beijing, Beijing, China |
| COCOCapital | China, Shanghai |
| CVCapital | China, Shanghai |
| Cycle Ventures | - |
| Gemba Capital | Bangalore, India, Karnataka |
| Gracenote | California, Emeryville, United States |
| Guosen H&S Investments | China, Fujian, Futian |
| Inforich | China, Jiangsu, Nanjing |
| Jounce NN | Bellevue, United States, Washington |
| Juhe Brothers Holdings | China, Fujian, Haicang |
| Lixil Group Corporation | Japan, Tokyo |
| LORE Associates | Pennsylvania, United States, Wayne |
| MLG BlockChain | - |
| Relativity | Chicago, Illinois, United States |
| Reliance Industrial Investments and Holdings | India, Maharashtra, Mumbai |
| Shanghai Tianji Chuangtou | China, Shanghai |
| Simon Equity Partners, LLC | California, San Francisco, United States |
| Triglav d.d. | Ljubljana, Ljubljana Urban Commune, Slovenia |
| VGangels | - |
| ZZ Capital | Beijing, Beijing, China |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Keros Therapeutics | $56M | 04 Mar 2020 | Massachusetts, United States | ||
Keros Therapeutics | $23M | 08 Jan 2019 | Massachusetts, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Keros Therapeutics | $56M | 04 Mar 2020 | Massachusetts, United States | ||
Keros Therapeutics | $23M | 08 Jan 2019 | Massachusetts, United States |
